Company Filing History:
1 out of 2 
1 out of 26 
Years Active: 2025
Title: Anna Konopka: Innovator in Epileptogenesis Research
Introduction
Anna Konopka is a notable inventor based in Warszawa, Poland. She has made significant contributions to the field of neuroscience, particularly in the area of epilepsy research. Although she currently holds no granted patents, her work is focused on innovative approaches to treating and preventing epileptogenesis.
Latest Patent Applications
Anna Konopka's latest patent application is titled "Use Of Marimastat For Preventing And/Or Treating Epileptogenesis." This invention relates to the use of marimastat or a pharmaceutically acceptable salt, solvate, or polymorph thereof in preventing or treating epileptogenesis in subjects who have suffered a brain insult. The brain insults addressed include stroke, traumatic brain injury, or status epilepticus, which may arise from structural or metabolic causes. The application emphasizes that marimastat or its acceptable salts should be administered preferably within the first 24 hours after the induction of epileptogenesis.
Conclusion
Anna Konopka's research and innovative applications in the field of epilepsy highlight her commitment to advancing medical science. Her work has the potential to significantly impact the treatment of brain injuries and related conditions.